ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Quantum Leap Healthcare, G1 Therapeutics Announce Trilaciclib Evaluation americanpharmaceuticalreview
January 16, 2020Quantum Leap Healthcare Collaborative? and G1 Therapeutics announced a collaboration to evaluate trilaciclib, an investigational therapy designed to improve outcomes for people with cancer treated with chemotherapy, in a new randomized ... -
G1 tanks after placebo beats drug in cancer response rate test
fiercebiotech
December 25, 2018G1 Therapeutics’ cancer drug trilaciclib has?failed?to beat placebo against multiple efficacy measures in phase 2. Trilaciclib performed well against its neutropenia-related primary endpoints but....
Pharma Sources Insight January 2025
